Regeneron Pharmaceuticals REGN Balance Sheet (2009-2026)

NASDAQ REGN
$827.72 -15.75 (-1.87%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Regeneron Pharmaceuticals Quarterly Balance Sheet

Periods 69 quarters
Latest Jun 2026

Regeneron Pharmaceuticals reported total assets of $41.73B and total liabilities of $10.02B for the quarter ended Jun 2026, up 9.2% year over year. This balance sheet covers 69 quarters of results from Jun 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
3.43B2.89B3.35B3.40B3.49B3.11B3.92B1.94B2.15B2.73B2.60B1.92B2.01B2.49B3.09B2.00B2.51B3.12B2.96B2.46B
Short-term InvestmentsInvestments (Current)
2.36B2.81B3.70B4.17B3.53B4.64B5.04B6.99B7.76B8.11B7.92B7.89B7.78B6.52B5.26B5.47B5.94B5.49B5.79B5.54B
Cash & Current Investments
5.79B5.69B7.05B7.57B7.02B7.74B8.96B8.93B9.91B10.84B10.52B9.81B9.80B9.01B8.35B7.47B8.44B8.61B8.75B7.99B
Receivables - NetNet Receivables
5.45B6.04B4.84B5.16B5.55B5.33B5.12B5.12B5.58B5.67B5.22B5.72B6.11B6.21B5.56B5.61B5.69B5.74B5.73B6.57B
Receivables - OtherOther Receivables
Receivables
5.45B6.04B4.84B5.16B5.55B5.33B5.12B5.12B5.58B5.67B5.22B5.72B6.11B6.21B5.56B5.61B5.69B5.74B5.73B6.57B
Inventory
2.05B1.95B1.99B2.22B2.41B2.40B2.42B2.51B2.56B2.58B2.71B2.87B3.02B3.09B3.19B3.21B3.25B3.20B3.10B3.08B
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
0.48B0.33B0.42B0.58B0.45B0.41B0.41B0.37B0.57B0.39B0.41B0.68B0.41B0.35B0.47B0.57B0.60B0.47B0.62B0.80B
Current Assets
13.78B14.01B14.31B15.53B15.43B15.88B16.91B16.92B18.63B19.48B18.87B19.08B19.33B18.66B17.57B16.86B17.98B18.02B18.21B18.45B
Non-Current Assets
Buildings
Construction in Progress
Property, Plant & Equipment (Net)PP&E (Net)
3.40B3.48B3.56B3.64B3.70B3.76B3.88B3.92B4.01B4.15B4.23B4.31B4.44B4.60B4.69B4.84B5.00B5.12B5.27B5.46B
Long-Term Investments
5.63B6.84B7.08B6.42B5.97B6.59B6.07B6.33B5.78B5.40B6.98B7.72B8.49B8.90B9.28B10.06B10.29B10.26B9.79B9.83B
Intangibles
0.01B0.96B0.92B0.93B0.95B1.02B1.04B1.06B1.10B1.12B1.15B1.17B1.35B1.38B1.26B1.29B1.31B
Goodwill & Intangibles
0.01B0.96B0.92B0.93B0.95B1.02B1.04B1.06B1.10B1.12B1.15B1.17B1.35B1.38B1.26B1.29B1.31B
Long-Term Deferred Tax
0.72B0.88B1.14B1.35B1.45B1.72B1.92B2.14B2.32B2.58B2.76B2.88B3.02B3.31B3.44B3.57B3.85B4.08B4.19B4.38B
Other Non-Current Assets
0.15B0.22B0.26B0.27B0.32B0.34B0.35B0.39B0.41B0.44B0.47B0.99B1.04B1.14B1.39B1.54B1.67B1.82B2.13B2.31B
Non-Current Assets
9.90B11.42B12.04B11.68B12.25B13.33B13.15B13.73B13.53B13.60B15.50B17.01B18.11B19.10B19.97B21.36B22.19B22.54B22.66B23.28B
Assets
23.67B25.43B26.35B27.21B27.68B29.21B30.06B30.66B32.16B33.08B34.37B36.09B37.44B37.76B37.55B38.22B40.17B40.56B40.87B41.73B
Liabilities
Current Liabilities
Accounts Payables
0.43B0.56B0.47B0.53B0.54B0.59B0.60B0.55B0.54B0.61B0.67B0.56B0.50B0.79B0.71B0.72B0.90B0.94B1.03B1.16B
Notes Payables
Payables
0.43B0.56B0.47B0.53B0.54B0.59B0.60B0.55B0.54B0.61B0.67B0.56B0.50B0.79B0.71B0.72B0.90B0.94B1.03B1.16B
Accumulated Expenses
2.06B2.21B2.05B1.93B1.80B2.07B2.07B2.18B2.64B2.36B2.39B2.36B2.54B2.53B2.24B2.46B2.98B2.88B2.72B2.97B
Other Accumulated Expenses
Short term Debt
Current Leases
0.72B0.72B0.72B0.72B
Current Deferred Revenue
0.51B0.44B0.49B0.57B0.55B0.48B0.43B0.38B0.42B0.46B0.52B0.59B0.63B0.63B0.62B0.48B0.55B0.55B0.64B0.68B
Total Current Liabilities
3.71B3.93B3.01B3.03B2.88B3.14B3.10B3.10B3.60B3.42B3.58B3.51B3.66B3.94B3.57B3.67B4.43B4.37B5.11B5.53B
Non-Current Liabilities
Capital Leases
0.72B0.72B0.72B0.72B0.72B0.72B0.72B0.72B0.72B0.72B0.72B0.72B0.72B0.72B0.72B0.72B
Non-Current Debt
1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.99B1.99B1.99B1.99B1.99B
Convertible Debt
Non-Current Deffered Revenue
0.06B0.07B0.03B0.06B0.06B0.07B0.09B0.12B0.13B0.13B0.19B0.21B0.21B0.19B0.21B0.21B0.22B0.21B0.23B0.22B
Operating Leases
0.79B0.81B0.95B0.99B
Other Non-Current Liabilities
0.66B0.68B0.69B0.72B0.60B0.64B0.68B0.72B0.83B0.85B0.91B1.46B1.54B1.57B1.67B1.70B1.86B2.02B2.13B2.28B
Total Non-Current Liabilities
5.75B5.99B5.74B5.79B5.64B5.91B5.89B5.92B6.43B6.25B6.47B6.42B6.57B6.83B6.48B6.58B7.35B7.28B7.32B7.74B
Total Liabilities
6.41B6.67B6.43B6.52B6.24B6.55B6.56B6.64B7.26B7.11B7.38B7.88B8.12B8.41B8.16B8.28B9.21B9.30B9.45B10.02B
Shareholder's Equity
Total Debt
1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.98B1.99B1.99B1.99B1.99B1.99B
Common Equity
17.26B18.77B19.91B20.69B21.44B22.66B23.50B24.02B24.90B25.97B26.99B28.21B29.33B29.35B29.39B29.94B30.96B31.26B31.42B31.71B
Liabilities and Shareholders Equity
23.67B25.43B26.35B27.21B27.68B29.21B30.06B30.66B32.16B33.08B34.37B36.09B37.44B37.76B37.55B38.22B40.17B40.56B40.87B41.73B
Treasury Shares
0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.04B
Retained Earnings
16.74B18.97B19.94B20.79B22.11B23.31B24.12B25.09B26.10B27.26B27.98B29.41B30.76B31.67B32.38B33.68B35.05B35.80B36.42B37.62B
Preferred Shares